Jim Simons Aurinia Pharmaceuticals Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,157,800 shares of AUPH stock, worth $13.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,157,800

Previous 938,600 23.35%

Holding current value

$13.4 Million

Previous $7.55 Million 29.95%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$7.2 - $8.64 $1.58 Million - $1.89 Million	219,200 Added 23.35%	1,157,800 $9.81 Million
Q1 2025 May 14, 2025	BUY	$7.55 - $8.77 $1.79 Million - $2.08 Million	237,700 Added 33.91%	938,600 $7.55 Million
Q4 2024 Feb 13, 2025	BUY	$6.75 - $10.44 $1.45 Million - $2.24 Million	214,200 Added 44.01%	700,900 $6.29 Million
Q3 2024 Nov 13, 2024	BUY	$5.32 - $7.33 $1.52 Million - $2.09 Million	285,200 Added 141.54%	486,700 $3.57 Million
Q2 2024 Aug 09, 2024	SELL	$4.81 - $5.78 $207,310 - $249,118	-43,100 Reduced 17.62%	201,500 $1.15 Million
Q1 2024 May 13, 2024	BUY	$4.93 - $9.31 $540,328 - $1.02 Million	109,600 Added 81.19%	244,600 $1.23 Million
Q4 2023 Feb 13, 2024	SELL	$7.13 - $9.49 $3.76 Million - $5.01 Million	-528,000 Reduced 79.64%	135,000 $1.21 Million
Q3 2023 Nov 14, 2023	SELL	$7.77 - $12.27 $6.74 Million - $10.6 Million	-867,400 Reduced 56.68%	663,000 $5.15 Million
Q2 2023 Aug 11, 2023	SELL	$8.96 - $11.69 $482,048 - $628,922	-53,800 Reduced 3.4%	1,530,400 $14.8 Million
Q1 2023 May 12, 2023	SELL	$5.94 - $11.27 $409,860 - $777,630	-69,000 Reduced 4.17%	1,584,200 $17.4 Million
Q4 2022 Feb 13, 2023	BUY	$4.11 - $8.14 $3.78 Million - $7.48 Million	919,400 Added 125.29%	1,653,200 $7.14 Million
Q3 2022 Nov 14, 2022	BUY	$6.66 - $12.39 $900,432 - $1.68 Million	135,200 Added 22.59%	733,800 $5.52 Million
Q2 2022 Aug 12, 2022	SELL	$8.95 - $12.8 $9.81 Million - $14 Million	-1,095,600 Reduced 64.67%	598,600 $6.02 Million
Q1 2022 May 13, 2022	BUY	$10.05 - $22.48 $12.3 Million - $27.6 Million	1,227,129 Added 262.73%	1,694,200 $21 Million
Q4 2021 Feb 11, 2022	BUY	$17.78 - $33.08 $8.3 Million - $15.5 Million	467,071 New	467,071 $10.7 Million
Q4 2020 Feb 10, 2021	SELL	$12.94 - $16.05 $3.1 Million - $3.84 Million	-239,400 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$13.19 - $16.66 $12.1 Million - $15.3 Million	-918,100 Reduced 79.32%	239,400 $3.53 Million
Q2 2020 Aug 13, 2020	SELL	$14.12 - $18.33 $3.97 Million - $5.16 Million	-281,300 Reduced 19.55%	1,157,500 $18.8 Million
Q1 2020 May 14, 2020	BUY	$11.34 - $21.46 $9.76 Million - $18.5 Million	860,266 Added 148.7%	1,438,800 $20.9 Million
Q4 2019 Feb 13, 2020	BUY	$3.88 - $21.42 $2.2 Million - $12.2 Million	567,789 Added 5284.22%	578,534 $11.7 Million
Q3 2019 Nov 13, 2019	SELL	$5.34 - $6.59 $309,068 - $381,416	-57,878 Reduced 84.34%	10,745 $57,000
Q2 2019 Aug 12, 2019	SELL	$6.05 - $6.75 $672,015 - $749,769	-111,077 Reduced 61.81%	68,623 $452,000
Q1 2019 May 14, 2019	BUY	$6.06 - $7.64 $1.09 Million - $1.37 Million	179,700 New	179,700 $1.17 Million

Others Institutions Holding AUPH

# of Institutions

245

Shares Held

62.5M

Call Options Held

1.03M

Put Options Held

666K

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.64B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account